Wellington Management Group
MRTX

Wellington Management Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Wellington Management Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,319,922
Closed -$145M – 1956
2023
Q3 		$145M Sell
3,319,922
-68,443
-2% -$2.44M 0.03% 444
2023
Q2 		$122M Buy
3,388,365
+692,273
+26% +$28.5M 0.02% 495
2023
Q1 		$100M Sell
2,696,092
-320,243
-11% -$14.4M 0.02% 536
2022
Q4 		$137M Sell
3,016,335
-452,976
-13% -$29.3M 0.03% 462
2022
Q3 		$242M Buy
3,469,311
+563,281
+19% +$41.7M 0.05% 323
2022
Q2 		$195M Buy
2,906,030
+423,509
+17% +$26.9M 0.04% 380
2022
Q1 		$204M Sell
2,482,521
-664,294
-21% -$67.9M 0.04% 412
2021
Q4 		$462M Sell
3,146,815
-293,407
-9% -$45.6M 0.07% 247
2021
Q3 		$609M Buy
3,440,222
+336,737
+11% +$54.2M 0.1% 199
2021
Q2 		$501M Buy
3,103,485
+917,067
+42% +$147M 0.08% 234
2021
Q1 		$375M Sell
2,186,418
-68,464
-3% -$13.6M 0.07% 288
2020
Q4 		$495M Buy
2,254,882
+617,462
+38% +$133M 0.09% 217
2020
Q3 		$272M Sell
1,637,420
-167,281
-9% -$22.9M 0.06% 293
2020
Q2 		$206M Buy
1,804,701
+68,744
+4% +$6.67M 0.05% 343
2020
Q1 		$133M Buy
1,735,957
+1,140,777
+192% +$102M 0.04% 400
2019
Q4 		$76.7M Buy
595,180
+444,295
+294% +$42.9M 0.02% 642
2019
Q3 		$11.8M Buy
150,885
+106,538
+240% +$10M ﹤0.01% 1108
2019
Q2 		$4.57M Buy
44,347
+34,658
+358% +$2.7M ﹤0.01% 1396
2019
Q1 		$710K Buy
+9,689
New +$659K ﹤0.01% 1834
2018
Q3 		– Sell
-9,522
Closed -$469K – 2337
2018
Q2 		$469K Buy
+9,522
New +$360K ﹤0.01% 2056

Other funds holding MRTX

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return

Wellington Management Group's MRTX Position: Q4 2023 in Review

Wellington Management Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2023, closing a stake of 3,319,922 shares — an estimated $145M sold.

Wellington Management Group first reported a position in MRTX in Q2 2018 and held it in 20 quarters. The position peaked at $609M in Q3 2021. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.

  • Wellington Management Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Wellington Management Group sold 3,319,922 Mirati Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $145M.
  • Wellington Management Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • Wellington Management Group's Mirati Therapeutics, Inc. Common Stock position peaked at $609M in Q3 2021.
  • 217 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Wellington Management Group's 13F filing for Q4 2023, filed 12 Feb 2024.